# EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant

> **NCT02968511** · NA · WITHDRAWN · sponsor: **Milton S. Hershey Medical Center**

## Conditions studied

- C.Difficile Colitis

## Interventions

- **BIOLOGICAL:** fecal microbiota transplant

## Key facts

- **NCT ID:** NCT02968511
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-09-15
- **Primary completion:** 2017-11-14
- **Final completion:** 2017-11-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of eligible patients
- **Last updated:** 2017-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02968511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02968511, "EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02968511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*